Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

Clinical trial NCT01440270 · COMPLETED

Trial details

NCT number: NCT01440270
Sponsor: Shanghai Jiao Tong University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Malignant Neoplasm Oral Cancer Oropharyngeal Carcinoma

Start date: 2011-08-01
Primary completion: 2014-10-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.